Cargando…

Early Growth Hormone Initiation Leads to Favorable Long-Term Growth Outcomes in Children Born Small for Gestational Age

CONTEXT: Early initiation of growth hormone (GH) therapy is recommended for short children born small for gestational age (SGA); however, real-world data indicate that treatment is often delayed. OBJECTIVE: We aimed to assess the impact of patient age at GH therapy initiation on long-term growth out...

Descripción completa

Detalles Bibliográficos
Autores principales:	Juul, Anders, Backeljauw, Philippe, Cappa, Marco, Pietropoli, Alberto, Kelepouris, Nicky, Linglart, Agnès, Pfäffle, Roland, Geffner, Mitchell
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2022
Materias:	Clinical Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10099159/ https://www.ncbi.nlm.nih.gov/pubmed/36469726 http://dx.doi.org/10.1210/clinem/dgac694

Ejemplares similares

Effectiveness and Safety of Early Growth Hormone Treatment in Children Born Small for Gestational Age: Long-Term Data From NordiNet® International Outcome Study (IOS) and ANSWER Program
por: Juul, Anders, et al.
Publicado: (2021)

Abstract 2: Effectiveness and safety of early growth hormone treatment in children born small for gestational age: Long-term data from NordiNet® International Outcome Study (IOS) and ANSWER program
por: Ranjan, K M, et al.
Publicado: (2022)

RF26 | PMON335 Once-Weekly Somapacitan Versus Daily Growth Hormone in Children Born Small for Gestational Age: Results From a Randomized Phase 2 Trial
por: Juul, Anders, et al.
Publicado: (2022)

Factors Associated With Response to Growth Hormone in Pediatric Growth Disorders: Results of a 5-year Registry Analysis
por: Ross, Judith, et al.
Publicado: (2023)

LBMON197 Predictors Of Response To Growth Hormone Treatment In Pediatric Growth Disorders: Analysis From The Answer Program And Nordinet® IOS
por: Ross, Judith L, et al.
Publicado: (2022)

Long-Term Safety of Growth Hormone Treatment in Childhood: Two Large Observational Studies: NordiNet IOS and ANSWER
por: Sävendahl, Lars, et al.
Publicado: (2021)

Cardiovascular safety of growth hormone treatment in Noonan syndrome: real-world evidence
por: Romano, Alicia, et al.
Publicado: (2021)

Outcomes in children treated with growth hormone for Prader-Willi syndrome: data from the ANSWER Program® and NordiNet® International Outcome Study
por: Angulo, Moris, et al.
Publicado: (2020)

Outcomes in growth hormone-treated Noonan syndrome children: impact of PTPN11 mutation status
por: Jorge, Alexander A L, et al.
Publicado: (2022)

Early GH Treatment Is Effective and Well Tolerated in Children With Turner Syndrome: NordiNet(®) IOS and Answer Program
por: Backeljauw, Philippe, et al.
Publicado: (2023)

Growth Hormone Replacement Therapy: Transition from Adolescence to Adulthood
por: Geffner, Mitchell E.
Publicado: (2009)

A randomized pilot trial of growth hormone with anastrozole versus growth hormone alone, starting at the very end of puberty in adolescents with idiopathic short stature
por: Rothenbuhler, Anya, et al.
Publicado: (2015)

The Variability of Growth and Puberty in Growth Hormone-treated Children Born Small for Gestational Age
por: Saroufim, Rita, et al.
Publicado: (2022)

Erratum to: A randomized pilot trial of growth hormone with anastrozole versus growth hormone alone, starting at the very end of puberty in adolescents with idiopathic short stature
por: Rothenbuhler, Anya, et al.
Publicado: (2017)

Adult Growth Hormone Deficiency: Diagnostic and Treatment Journeys From the Patients’ Perspective
por: Hoffman, Andrew R, et al.
Publicado: (2022)

THU008 Coverage Of Education And Training Of Traumatic Brain Injury-induced Growth Hormone Deficiency In US Endocrinology Fellowship Programs
por: Ji Yuen, Kevin Choong, et al.
Publicado: (2023)

Efficacy and safety of growth hormone treatment for children born small for gestational age
por: Hwang, Il Tae
Publicado: (2014)

Methylphenidate and the Response to Growth Hormone Treatment in Short Children Born Small for Gestational Age
por: Renes, Judith S., et al.
Publicado: (2012)

Somatotropin in the treatment of growth hormone deficiency and Turner syndrome in pediatric patients: a review
por: Reh, Christina Southern, et al.
Publicado: (2010)

Efficacy of growth hormone replacement on anthropometric outcomes, obesity, and lipids in children with optic nerve hypoplasia and growth hormone deficiency
por: Stewart, Carly, et al.
Publicado: (2016)

Genetic and Epigenetic Modulation of Growth Hormone Sensitivity Studied With the IGF-1 Generation Test
por: Ouni, Meriem, et al.
Publicado: (2015)

Quality of Life of Short-Statured Children Born Small for Gestational Age or Idiopathic Growth Hormone Deficiency Within 1 Year of Growth Hormone Treatment
por: Quitmann, Julia, et al.
Publicado: (2019)

Post-Receptor Crosstalk between Growth Hormone and Insulin Signal in Rats Born Small for Gestational Age with Catch-Up Growth
por: Deng, Hong-Zhu, et al.
Publicado: (2014)

Long-term effectiveness of growth hormone therapy in children born small for gestational age: An analysis of LG growth study data
por: Lee, Hae Sang, et al.
Publicado: (2022)

Ten years’ clinical experience with biosimilar human growth hormone: a review of efficacy data
por: López-Siguero, Juan Pedro, et al.
Publicado: (2017)

Prevalence of children born small for gestational age with short stature who qualify for growth hormone treatment
por: Tamaro, Gianluca, et al.
Publicado: (2021)

Growth hormone effect on body composition of children born small for gestational age: a systematic review
por: Kühl, Adriana M., et al.
Publicado: (2022)

Long-Term Efficacy and Safety of Recombinant Human Growth Hormone in Children Born Small for Gestational Age
por: Wu, Wei, et al.
Publicado: (2023)

Growth pattern in children with X-linked hypophosphatemia treated with burosumab and growth hormone
por: Ertl, Diana-Alexandra, et al.
Publicado: (2022)

Lack of Catch-Up Growth with Growth Hormone Treatment in a Child Born Small for Gestational Age Leading to a Diagnosis of Noonan Syndrome with a Pathogenic PTPN11 Variant
por: Olivieri, Daniel J., et al.
Publicado: (2021)

Poor growth response during the first year of growth hormone treatment in short prepubertal children with growth hormone deficiency and born small for gestational age: a comparison of different criteria
por: Straetemans, Saartje, et al.
Publicado: (2018)

Safety and Efficacy of Pediatric Growth Hormone Therapy: Results From the Full KIGS Cohort
por: Maghnie, Mohamad, et al.
Publicado: (2022)

Effect of oxandrolone therapy on adult height in Turner syndrome patients treated with growth hormone: a meta-analysis
por: Sheanon, Nicole M., et al.
Publicado: (2015)

PMON60 Growth Hormone (GH) Replacement Therapy (GHRT) in Patients with Adult GH Deficiency (AGHD) Aged ≥60 Years: Data from NordiNet® IOS and the ANSWER Program
por: Biller, Beverly, et al.
Publicado: (2022)

Three years of growth hormone therapy in children born small for gestational age: results from the ANSWER Program
por: Rapaport, Robert, et al.
Publicado: (2018)

Growth response of syndromic versus non-syndromic children born small for gestational age (SGA) to growth hormone therapy: a Belgian study
por: Becker, Marianne, et al.
Publicado: (2023)

Favorable Impact of Growth Hormone Treatment on Cholesterol Levels in Turner Syndrome
por: Kohno, Hitoshi, et al.
Publicado: (2012)

Favorable Growth Hormone Treatment Response in a Young Boy with Achondroplasia
por: Krstevska-Konstantinova, Marina, et al.
Publicado: (2016)

The long-term safety and effectiveness of growth hormone treatment in Japanese children with short stature born small for gestational age
por: Horikawa, Reiko, et al.
Publicado: (2020)

Adult height and health-related quality of life in patients born small for gestational age treated with recombinant growth hormone
por: Rodrígez, José Manuel Rial, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_e9p7ip2fk4aacn06mulhkv7d6s